Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Revenue (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Revenue over the past 16 years, most recently at $36.4 million for Q2 2025.

  • Quarterly results put Revenue at $36.4 million for Q2 2025, down 3.81% from a year ago — trailing twelve months through May 2025 was $128.9 million (changed 0.47% YoY), and the annual figure for FY2025 was $128.9 million, changed 0.47%.
  • Revenue for Q2 2025 was $36.4 million at Lifecore Biomedical, Inc. \De\, up from $35.2 million in the prior quarter.
  • Over the last five years, Revenue for LFCR hit a ceiling of $44.9 million in Q2 2021 and a floor of $21.9 million in Q4 2022.
  • Median Revenue over the past 5 years was $29.1 million (2022), compared with a mean of $30.2 million.
  • Biggest five-year swings in Revenue: plummeted 81.82% in 2021 and later surged 37.9% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Revenue stood at $25.6 million in 2021, then fell by 14.6% to $21.9 million in 2022, then soared by 37.9% to $30.2 million in 2023, then increased by 8.01% to $32.6 million in 2024, then grew by 11.91% to $36.4 million in 2025.
  • The last three reported values for Revenue were $36.4 million (Q2 2025), $35.2 million (Q1 2025), and $32.6 million (Q4 2024) per Business Quant data.